MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis
Authors:
Open Access
- 22 September 2015
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (32) , 32545-32560
Abstract
MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysisKeywords
This publication has 77 references indexed in Scilit:
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaBMC Cancer, 2014
- MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaBMC Cancer, 2012
- MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinomaTumor Biology, 2012
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patientsGenes, Chromosomes and Cancer, 2012
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancerCarcinogenesis, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005